Media stories about Rewalk Robotics (NASDAQ:RWLK) have trended somewhat positive this week, according to Accern Sentiment Analysis. The research group rates the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Rewalk Robotics earned a media sentiment score of 0.18 on Accern’s scale. Accern also gave news coverage about the medical device company an impact score of 45.7922351793357 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
These are some of the media stories that may have impacted Accern Sentiment’s scoring:
- Rewalk Robotics (RWLK) Scheduled to Post Earnings on Thursday (americanbankingnews.com)
- Rewalk Robotics (RWLK) Raised to Sell at ValuEngine (americanbankingnews.com)
- Analysts Expect Rewalk Robotics Ltd (RWLK) Will Post Quarterly Sales of $1.78 Million (americanbankingnews.com)
- ReWalk Robotics wins German reimbursement nod for Personal 6.0 exoskeleton (massdevice.com)
- Rewalk Robotics Ltd (RWLK) Receives Consensus Rating of “Hold” from Brokerages (americanbankingnews.com)
Shares of Rewalk Robotics (NASDAQ:RWLK) traded down $0.05 during midday trading on Thursday, hitting $1.05. The company had a trading volume of 215,806 shares, compared to its average volume of 275,611. The company has a quick ratio of 1.65, a current ratio of 2.02 and a debt-to-equity ratio of 7.46. The firm has a market cap of $30.37, a PE ratio of -0.66 and a beta of 0.83. Rewalk Robotics has a twelve month low of $1.05 and a twelve month high of $3.20.
WARNING: This piece was first published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece on another domain, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this piece can be viewed at https://www.com-unik.info/2018/02/08/rewalk-robotics-rwlk-receives-daily-coverage-optimism-rating-of-0-18.html.
Rewalk Robotics Company Profile
ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.
Receive News & Ratings for Rewalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rewalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.